Natco’s generic SMA drug approved; ‘clinical trial’ labels trigger Kerala row | India News
SAT Hospital authorities have maintained that the medicine distributed was the approved generic formulation NEW DELHI: Days after a controversy erupted in Kerala over Natco Pharma’s generic drug for spinal muscular atrophy (SMA), regulatory clarifications suggest the row stemmed from labels on bottles supplied free of cost. The words “Physician Sample/Clinical Trial” raised fears among…